(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
This is a phase-III clinical trial to compare a combination of the drugs ALIMTA plus GEMZAR versus GEMZAR alone in patients with unresectable or metastatic cancer of the pancreas. Patients may be able to participate if they have cancer of the pancreas that cannot be removed by surgery, or that has spread to a new site in the body. Research sites located throughout the world.
Please see http://www.centerwatch.com/patient/studies/cat35.html.
This research study will determine the effectiveness of an oral investigational drug for the treatment of metastatic colorectal cancer, after the patient has received prior therapy with irinotecan (CPT-11) plus 5-fluorouracil (5-FU). Research sites located throughout the world.
Please see http://www.centerwatch.com/patient/studies/cat426.html.
Schizophrenia and Schizoaffective Disorders
This research study will compare the effectiveness and tolerability of certain antipsychotic medications for the treatment of schizophrenia, schizophreniform disorder, or schizoaffective disorder in patients experiencing their first psychotic episodes. Research site located in New York, NY.
Please see http://www.centerwatch.com/patient/studies/cat135.html.
Copyright 2002 CenterWatch. All rights reserved.